Uritro Capsule (Sustained Release) 50 mg is an antibiotic medication used primarily to treat bladder infections. It's used to treat most types of urinary tract infections in both adults and children. It works by stopping bacteria from growing in the bladder and urinary system.
Uritro Capsule (Sustained Release) 50 mg is used to treat urinary tract infections, including cystitis and bladder infections. It is also used to prevent recurrence of these infections.
| Brand Name | Uritro |
|---|---|
| Type | Capsule (Sustained Release) |
| Weight | 50 mg |
| Generic | Nitrofurantoin |
| Manufacturer | Team Pharmaceuticals Ltd. |
| Available in | English বাংলা |
Uritro Capsule (Sustained Release) 50 mg works by inhibiting bacterial enzymes essential for the synthesis of DNA and cell wall production. This prevents bacteria from producing new cells and stops their growth.
Uritro Capsule (Sustained Release) 50 mg usually takes 2 to 3 days to start working. Some people may notice improvement after only one day.
Uritro Capsule (Sustained Release) 50 mg is only partially and slowly absorbed into the blood after being taken orally. Its concentration in the blood is typically low.
Uritro Capsule (Sustained Release) 50 mg is primarily eliminated in urine. It is excreted in the urine as a mixture of unchanged drug and its metabolites.
Uritro Capsule (Sustained Release) 50 mg is available in the form of tablets, capsules, and suspension. It is usually taken two or three times a day for 5 to 10 days, depending on the severity of the infection.
Uritro Capsule (Sustained Release) 50 mg should be taken at least 2 hours after eating and on an empty stomach. It should also be taken with plenty of fluids to help reduce the risk of crystals forming in the urine.
Common side effects of nitrofurantoin include nausea, vomiting, headache, fever, rash, and abdominal pain. It can also cause diarrhea and changes in blood tests.
Uritro Capsule (Sustained Release) 50 mg is generally well tolerated and has a low risk of toxicity. However, overdose or misuse can lead to serious side effects such as kidney damage and anemia.
It is important to follow your doctor's instructions when taking nitrofurantoin. Do not take more than your prescribed dose and take it with plenty of fluids to reduce the risk of kidney stones forming.
Uritro Capsule (Sustained Release) 50 mg may interact with certain medications, herbal supplements, and vitamins. Before taking this medication, be sure to tell your doctor about all the medications you are taking.
Uritro Capsule (Sustained Release) 50 mg may interact with certain chronic medical conditions such as chronic kidney disease or anemia. It is important to tell your doctor about any chronic conditions before taking this medication.
Uritro Capsule (Sustained Release) 50 mg may interact with common medications such as antacids, laxatives, and vitamins. Be sure to tell your doctor about all the medications you are taking before taking this medication.
Uritro Capsule (Sustained Release) 50 mg should be taken on an empty stomach. It should not be taken with food or milk.
Uritro Capsule (Sustained Release) 50 mg should only be used during pregnancy if the potential benefit justifies the potential risk to the fetus. It is important to discuss the risks and benefits of taking this medication with your doctor.
It is not known if nitrofurantoin passes into breast milk. Therefore, it should be used with caution in nursing mothers.
An overdose of nitrofurantoin can lead to serious side effects, including kidney damage and anemia. If you think you have taken too much of this medication, seek medical help immediately.
Uritro Capsule (Sustained Release) 50 mg should not be used in people with certain conditions such as kidney disease, anemia, certain blood disorders, and allergies to nitrofurantoin or similar medications.
Uritro Capsule (Sustained Release) 50 mg should be taken with plenty of fluids to prevent kidney stones forming and should be taken on an empty stomach, at least 2 hours after eating. It should be used for the full prescribed amount of time.
Uritro Capsule (Sustained Release) 50 mg should be stored in a cool, dry place away from direct light or moisture. Keep the container tightly closed and away from children.
Uritro Capsule (Sustained Release) 50 mg has a volume of distribution of about 0.6-1 L/kg.
The elimination half-life of nitrofurantoin is about 2-4 hours.
The clearance of nitrofurantoin from the body is about 25-29 mL/min/kg.
See in details version Uritro Capsule (Sustained Release) 50 mg also Uritro Capsule (Sustained Release) 50 mg in bangla
Prof. Brig. Gen. Dr. Md. Abdul Latif Khan
Skin, Leprosy, Sex, Allergy Specialist & Cosmetic Surgeon